Form 4/A for IDXX Idexx Laboratories
Accepted 2021-08-31 00:00:00 ET · period of report 2021-05-28 · accession 0001567619-21-016515 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2021-08-31 | 2021-05-28 | IDXX | Turner Kathy V | SVP | S - Sale | $558.44 | -2,000 | 2,866 | -41% | -$1.12M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-05-28 | S | D | 2,000 | $558.44 | 2,866 | D | — | — | (F1) Amendment is being filed to correct the number of shares of Issuer common stock held. |